Prednisone Delayed Release Tablet, Delayed Release
Product Images NDC 74157-010

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Prednisone Delayed Release (NDC 74157-010). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ina Pharmaceutics Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

1b (1mg Bottle)

Label for Prednisone delayed release tablets 1 mg by INA Pharmaceutics Inc. The label states the dosage form as delayed-release tablets, with each tablet containing 1 mg of prednisone. It includes NDC 74157-010-30 and specifies storage conditions between 20°C to 25°C. The package contains 30 tablets and is marked Rx only. Manufacturer information indicates INA Pharmaceutics Inc, Fairmont, WV, with the product origin as Spain.*

FDA Label Image

1c (1mg Carton)

Packaging label for Prednisone delayed release Tablets 1 mg by INA Pharmaceutics Inc. The label states the tablets are to be swallowed whole, not crushed, divided, or chewed. The package contains 30 tablets, Rx only. Storage instructions and dosage notes are included, along with a barcode and NDC 74157-010-30.*

FDA Label Image

2b (2mg Bottle)

Label for prednisone delayed-release tablets, 2 mg strength, manufactured by INA Pharmaceutics Inc. The label includes dosage instructions indicating to swallow tablets whole and not to crush, divide, or chew. Packaging contains 30 tablets, prescription only. Storage conditions are specified between 20°C to 25°C, with permitted excursions.*

FDA Label Image

2c (2mg Carton)

Carton packaging label for Prednisone delayed-release Tablets 2 mg by INA Pharmaceutics Inc. The label includes dosage instructions to swallow whole without crushing or chewing, a quantity of 30 tablets, and storage temperature guidelines. The product is indicated as Rx only and manufactured in Spain.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of prednisone, showing the steroid backbone with ketone and hydroxyl functional groups consistent with prednisone's molecular structure.*

FDA Label Image

Figure1 (Figure1)

A line graph showing prednisone plasma concentration (ng/mL) over time in hours after administration. It compares immediate-release prednisone 5 mg and delayed-release prednisone 5 mg tablets under semi-fed and fed conditions, illustrating variations in plasma concentration profiles over a 24-hour period.*

FDA Label Image

Figure2 (Figure2)

A line graph comparing the percentage of ACR20 responders over 12 weeks between two groups: Prednisone delayed-release tablets plus DMARD (N=231) and Placebo plus DMARD (N=119). The x-axis represents time in weeks, and the y-axis represents the percentage of responders, showing higher response rates in the Prednisone group at each time point.*

FDA Label Image

Logo (Ina Logo)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.